Idiopathic restrictive cardiomyopathy is a rare form of primary myocardial disease characterized by persistent restrictive physiology, reduced ventricular distensibility, elevated filling pressures, non-dilated ventricles and atrial dilatation, in the absence of a demonstrable specific cause after adequate exclusion of infiltrative, storage, endomyocardial, inflammatory, toxic, radiation-induced, pericardial or systemic diseases. The term “idiopathic” must therefore be interpreted with caution: it does not define an autonomous pathogenetic mechanism, but describes a condition in which the restrictive phenotype is not explained by a cause identified with the available clinical, laboratory, imaging, genetic and histological tools.
The pathophysiological core of the disease is the inability of the ventricles to receive an adequate blood volume during diastole without a disproportionate increase in intracavitary pressure. Unlike dilated cardiomyopathies, the ventricular cavity is not primarily enlarged; unlike classic hypertrophic forms, wall thickness may be normal or only mildly increased; unlike constrictive pericarditis, the limitation to filling does not derive from a rigid pericardial shell, but from intrinsic alterations of the myocardium and interstitium. This distinction is decisive because constrictive pericarditis may be potentially correctable surgically, whereas idiopathic restrictive cardiomyopathy currently has no specific etiological therapy.
From an epidemiological point of view, it is one of the rarest cardiomyopathies. Its true prevalence is unknown, because case series are limited, diagnosis requires a complex exclusion pathway and many forms once defined as idiopathic are now reclassified as genetic, infiltrative or storage diseases thanks to cardiac magnetic resonance imaging, bone scintigraphy with tracers for transthyretin amyloid, tissue characterization, endomyocardial biopsy and genetic panels. In childhood, restrictive cardiomyopathy accounts for a small proportion of cardiomyopathies, but has a high prognostic impact because it may rapidly progress to advanced heart failure, pulmonary hypertension, atrial arrhythmias, embolic events and the need for heart transplantation. In adults, the pure idiopathic form is even more difficult to delimit, since cardiac amyloidosis, hemochromatosis, sarcoidosis, autoimmune diseases, radiation-induced heart disease and late-onset genetic forms must be carefully excluded before retaining the idiopathic label.
Idiopathic restrictive cardiomyopathy belongs to the group of cardiomyopathies defined by the functional phenotype, not by a single cause. The common feature is restriction of ventricular filling: during early diastole, blood enters the ventricle rapidly, but pressure rises abruptly and prevents further filling. This produces a steep diastolic pressure-volume curve, with a small increase in volume associated with a large increase in pressure. This hemodynamic behavior explains why the patient may present with dyspnea, systemic venous congestion, exercise intolerance and atrial dilatation even when the left ventricular ejection fraction is still preserved.
The classic phenotype includes markedly dilated atria, ventricles of normal or reduced size, initially normal or only mildly impaired global systolic function, absence of primary ventricular dilatation and Doppler signs of restrictive filling. Biatrial dilatation is not a secondary detail: it represents the anatomical consequence of chronic atrial exposure to elevated filling pressures and is one of the most useful signs for suspecting the disease. When the atria become large, fibrotic and electrically unstable, the likelihood of atrial fibrillation, atrial flutter, atrial thrombosis and loss of the atrial contribution to ventricular filling increases.
The rarity of the idiopathic form makes it difficult to establish robust epidemiological figures. Pediatric series and cardiomyopathy registries indicate that the restrictive phenotype is much less frequent than dilated and hypertrophic cardiomyopathies, but its clinical severity is disproportionate to its frequency. In children, it may appear after years of apparent well-being with fatigue, dyspnea, syncope or signs of pulmonary hypertension; in other cases it is recognized incidentally after the finding of cardiomegaly, electrocardiographic abnormalities or atrial dilatation on echocardiography. Pediatric presentation always requires genetic and family evaluation, because a relevant proportion of forms defined as idiopathic may be linked to variants in sarcomeric or cytoskeletal genes.
In adults, diagnosis is often later because the picture may be confused with heart failure with preserved ejection fraction, hypertensive heart disease, atrioventricular valve disease, ischemic heart disease, isolated atrial fibrillation or constrictive pericarditis. The idiopathic form must remain a particularly rigorous diagnosis of exclusion: an elderly patient with a restrictive phenotype and thickened walls must be investigated for amyloidosis; a patient with abnormal serum iron, ferritin and transferrin saturation must be evaluated for iron overload; a patient with persistent eosinophilia should raise suspicion of eosinophilic endomyocardial disease; a patient with conduction blocks, muscle weakness, elevated creatine kinase or a family history should be directed toward a genetic or neuromuscular cause.
The adjective idiopathic, therefore, has an operational and temporary value. In the past it was used more broadly because the available tools did not allow many specific causes to be recognized. Today, modern classification requires distinguishing apparently idiopathic primary restrictive cardiomyopathy from secondary forms, recognized genetic forms, systemic diseases with cardiac involvement and restriction secondary to end-stage phases of other cardiomyopathies. Nosological precision is not merely academic, because some alternative diagnoses have specific treatments, family implications, prognostic implications and different surveillance pathways.
In idiopathic restrictive cardiomyopathy there is no definite etiological cause common to all patients. The diagnosis is retained only when amyloidosis, sarcoidosis, hemochromatosis, Anderson-Fabry disease, glycogen storage diseases, mitochondrial diseases, hypereosinophilia, endomyocardial fibrosis, radiation-induced heart disease, oncological cardiotoxicity, systemic autoimmune diseases, carcinoid heart disease, myocardial metastases or constrictive pericarditis cannot be demonstrated. This approach is essential because restrictive physiology is a final phenotype shared by very different diseases, not automatic proof of idiopathy.
When the disease remains classified as idiopathic after exclusion of secondary causes, the literature suggests that a proportion of cases may belong to genetically determined primary cardiomyopathies. The most relevant variants described in primary restrictive forms involve proteins of the sarcomere, cytoskeleton, Z-disc and myofibrillar architecture. Among the genes most frequently discussed are TNNI3, the gene encoding cardiac troponin I, TNNT2, the gene encoding cardiac troponin T, ACTC1, the gene encoding cardiac actin, MYH7, the gene encoding the beta-myosin heavy chain, MYBPC3, the gene encoding cardiac myosin-binding protein C, TPM1, the gene encoding alpha-tropomyosin, DES, the gene encoding desmin, FLNC, the gene encoding filamin C, CRYAB, the gene encoding alpha-B-crystallin, BAG3, a gene associated with myofibrillar proteostasis, and LMNA, the gene encoding lamin A/C. These genes do not all have the same strength of association, and the clinical significance of a variant must be interpreted using rigorous genetic criteria, family segregation and phenotypic correlation.
The most extensively studied pathogenetic mechanism concerns variants of cardiac troponin I. Troponin I is a regulatory component of the sarcomeric thin filament and helps switch off actin-myosin interaction during diastole when the cytosolic calcium concentration falls. Some variants associated with a restrictive phenotype increase myofilament calcium sensitivity or alter normal inhibition of actomyosin activity. The result is a mechanical relaxation abnormality in which the cardiomyocyte tends to maintain residual tension even when it should relax. This persistence of diastolic tone reduces ventricular compliance and makes filling more dependent on atrial pressures.
Alongside sarcomeric dysfunction, the cytoskeleton may also contribute to myocardial stiffness. Desmin connects myofibrils to one another, to the sarcolemma, to the nucleus and to mitochondria; filamin C participates in mechanical stability and stress signal transduction; Z-disc proteins organize myofibrillar alignment and the response to load. When these structures are altered, the cardiomyocyte loses part of its normal elastic architecture and may develop protein aggregate accumulation, myofibrillar disorganization, mechanical stress, activation of fibrotic pathways and electrical vulnerability. In these forms, the restrictive phenotype may coexist with conduction disturbances, skeletal myopathy, increased creatine kinase or ventricular arrhythmias, elements that should prompt reassessment of the idiopathic label.
The interstitial component is equally important. Even in the absence of a specific infiltrative disease, the myocardium may show increased extracellular matrix, interstitial fibrosis, altered collagen deposition and remodeling of cardiac fibroblasts. Increased fibrillar collagen and modification of cross-links between collagen fibers make the tissue less deformable. The ventricular wall, even if not thickened, becomes stiffer; the atrium must generate higher pressures to fill the ventricle; pulmonary venous pressure rises; the pulmonary circulation develops vasoconstriction and remodeling; the right ventricle is progressively exposed to increased pressure load.
The pathophysiological sequence can be described progressively. Initially, the defect in relaxation and compliance predominates, with preserved ejection fraction and intermittent increase in filling pressures during exertion. Subsequently, pressures become elevated even at rest, the atria dilate, pulmonary and systemic congestion appear, B-type natriuretic peptide or the N-terminal fragment of pro-B-type natriuretic peptide increases, and the patient develops reduced functional capacity. In advanced stages, prolonged exposure to high pressures induces post-capillary pulmonary hypertension, right ventricular dysfunction, functional tricuspid regurgitation, reduced cardiac output and, sometimes, secondary systolic impairment.
A distinctive aspect of restrictive physiology is dependence on heart rate and sinus rhythm. Since systolic stroke volume is relatively fixed, cardiac output can increase only modestly with exercise; if the heart rate is too low, output falls; if the heart rate is too high, filling time shortens and atrial pressure increases. Loss of atrial contraction in atrial fibrillation is particularly harmful because the stiff ventricle depends markedly on the atrial contribution to late filling. This vulnerability explains the poor clinical tolerance of atrial arrhythmias, significant bradycardia, atrioventricular blocks and medications that excessively reduce heart rate or preload.
Clinical evaluation begins with history-taking, because idiopathic restrictive cardiomyopathy may present with initially subtle and non-specific symptoms. The patient may report progressive reduction in exercise tolerance, dyspnea during activities previously well tolerated, disproportionate fatigue, need to slow down, orthopnea, nocturnal awakenings with air hunger, congestion-related cough, palpitations, dizziness or syncope. In children and adolescents, the signs may be less explicit: reduced participation in play or sport, poor weight gain, sweating, irritability, abdominal pain from hepatic congestion, syncopal episodes or incidental diagnosis after the finding of cardiomegaly.
The history must reconstruct the temporal sequence precisely. Slowly progressive dyspnea with non-dilated ventricles and markedly enlarged atria points toward restrictive physiology; onset after viral infection, fever or chest pain also suggests myocarditis; a picture associated with peripheral neuropathy, proteinuria, macroglossia or carpal tunnel syndrome should prompt investigation for amyloidosis; skin hyperpigmentation, diabetes, liver disease and arthropathy point toward iron overload; angiokeratomas, acroparesthesias, hypohidrosis and renal failure suggest Anderson-Fabry disease; eosinophilia, asthma, thrombotic manifestations or endocardial lesions direct the evaluation toward eosinophilic endomyocardial disease; muscle weakness, ptosis, exercise intolerance or elevated creatine kinase require suspicion of neuromuscular disease.
Family history carries substantial weight. Heart failure at a young age, sudden death, heart transplantation, early pacemaker implantation, implantable defibrillator, early atrial fibrillation, hypertrophic cardiomyopathy, dilated cardiomyopathy, skeletal myopathies and unexplained deaths should be investigated. An apparently sporadic presentation does not exclude a genetic basis, because de novo variants, incomplete penetrance, variable expressivity or relatives not yet studied may exist. In pediatric cases, in young adults and in patients with conduction disturbances or a family phenotype, genetic history is not an accessory element but a central part of the assessment.
On physical examination, the most frequent finding is congestion. Jugular venous pressure may be elevated and show prominent venous waves; tender hepatomegaly, hepatojugular reflux, dependent edema, ascites, pleural effusion and weight gain from salt and water retention may be present. Pulmonary congestion may manifest with basal crackles, reduced oxygen saturation during exertion or intolerance of the supine position. In cases with predominant right-sided involvement, dyspnea may be less evident than hepatomegaly, edema, abdominal distension and low-output asthenia.
Cardiac auscultation may reveal a gallop rhythm, third or fourth heart sound, murmurs from functional mitral or tricuspid regurgitation and rhythm irregularity in the case of atrial fibrillation. The pulse may be small if output is reduced, whereas hypotension or a narrow pulse pressure may indicate an advanced stage. Unlike constrictive pericarditis, the isolated physical finding does not allow reliable distinction, because both conditions may produce jugular venous distension, ascites, edema and hepatic congestion. For this reason, clinical examination must always be integrated with imaging, hemodynamic assessment and systematic search for alternative causes.
The presentation may be dominated by arrhythmias. Atrial fibrillation and atrial flutter are frequent because dilated and fibrotic atria become a substrate for re-entry circuits and disorganized electrical activity. When the arrhythmia appears, the patient may deteriorate abruptly: loss of atrial systole reduces filling of a stiff ventricle, rapid rate shortens diastole and increased atrial pressures intensify congestion. Atrioventricular blocks, bradyarrhythmias and conduction disturbances should raise suspicion of a genetic, infiltrative or neuromuscular basis and modify the therapeutic approach.
Syncope is a warning sign. It may result from low output during exertion, tachyarrhythmias, bradyarrhythmias, advanced pulmonary hypertension, functional obstruction to filling or pulmonary embolism. Chest pain may also occur, often not because of epicardial coronary stenosis but because of mismatch between oxygen demand and supply, increased wall pressures, reduced subendocardial perfusion or coronary microdysfunction. However, the presence of chest pain must not lead to neglecting coronary evaluation when age, risk factors or the electrocardiogram make it necessary.
The diagnostic pathway must begin with clinical suspicion of restrictive physiology and proceed in an orderly manner. The first objective is to demonstrate that the patient has a persistent restrictive phenotype; the second is to distinguish myocardial disease from constrictive pericarditis; the third is to search for all specific treatable or classifiable causes; only after these steps can the definition of idiopathic restrictive cardiomyopathy be retained. A diagnosis made only on the basis of dyspnea, preserved ejection fraction and dilated atria is insufficient, because many different conditions produce a similar picture.
The 12-lead electrocardiogram is a first-line test but provides very useful information. It may show atrial fibrillation, atrial flutter, signs of atrial overload, repolarization abnormalities, low voltages, bundle branch blocks, atrioventricular blocks, pseudo-infarct patterns or pre-excitation. The meaning is not uniform: low voltages disproportionate to ventricular wall thickness point toward amyloidosis; very high voltages, a short PR interval or pre-excitation may suggest storage diseases such as Anderson-Fabry, PRKAG2 or Danon disease; atrioventricular blocks and conduction disturbances are red flags for laminopathies, desminopathies, sarcoidosis or other infiltrative diseases. In a truly idiopathic form, the electrocardiogram may be non-specific, but it must not be ignored.
Transthoracic echocardiography is the key initial examination. It must assess ventricular size and wall thickness, systolic function, atrial size, diastolic function, filling pressures, right ventricular function, estimated pulmonary artery pressure, atrioventricular valves, inferior vena cava and signs of pericardial disease. Typical findings include dilated atria, non-dilated ventricles, preserved or moderately reduced left ventricular ejection fraction, restrictive mitral filling pattern, reduced deceleration time, increased E/e’ ratio, reduced tissue Doppler diastolic velocities and increased pulmonary pressures. Longitudinal myocardial deformation may help recognize patterns suggestive of amyloidosis or other diseases, but alone it is not sufficient to define idiopathy.
The distinction from constrictive pericarditis is one of the most important points in the entire pathway. Pericardial constriction limits filling through an external constraint, determines marked ventricular interdependence and produces characteristic respiratory variations in intracardiac flows. In restrictive cardiomyopathy, the limitation is intramyocardial; filling pressures are elevated, but respiratory variation in gradients and systolic discordance between the right and left ventricles are generally less marked. Doppler echocardiography, tissue Doppler, cardiac magnetic resonance imaging and, when necessary, cardiac catheterization allow the two pictures to be separated. Differential diagnosis is clinically decisive because an error may lead to unnecessary pericardiectomy or, conversely, to failure to treat potentially reversible constriction.
Cardiac magnetic resonance imaging adds morphological and tissue information. It must evaluate volumes, function, atria, ventricles, pericardium, pericardial thickening or enhancement, late gadolinium enhancement pattern, T1 mapping, extracellular volume, edema and, when indicated, T2* for iron overload. In the idiopathic form, it may document dilated atria and non-dilated ventricles without a specific infiltration pattern; diffuse subendocardial or transmural enhancement points toward amyloidosis; very low native T1 may suggest Anderson-Fabry disease or iron; reduced T2* indicates iron accumulation; patchy enhancement with possible involvement of the basal septum or extracardiac signs may point toward sarcoidosis. Magnetic resonance imaging is not used only to confirm restriction: above all, it is used to avoid improperly classifying a recognizable cause as idiopathic.
Laboratory tests must be aimed at confirming hemodynamic injury and excluding specific etiologies. B-type natriuretic peptide or the N-terminal fragment of pro-B-type natriuretic peptide documents wall stress and congestion; high-sensitivity troponin may indicate chronic or acute myocardial injury; complete blood count with differential searches for eosinophilia; creatinine, estimated glomerular filtration rate, proteinuria and albuminuria point toward amyloidosis or systemic diseases; ferritin and transferrin saturation assess iron overload; electrophoresis, serum and urine immunofixation and serum free light chains are essential to exclude light-chain amyloidosis; creatine kinase and lactate may suggest myopathy or mitochondrial disease; autoimmune tests should be requested when the clinical context suggests connective tissue disease, vasculitis or systemic inflammatory disease.
According to the approach of contemporary guidelines and specialist reviews, the diagnosis of idiopathic restrictive cardiomyopathy requires demonstration of a coherent sequence of clinical, morphological, functional and etiological data. The operational synthesis can be outlined as follows:
Right and left cardiac catheterization is not always necessary, but becomes very important when non-invasive data are discordant, when pulmonary hypertension must be defined, when heart transplantation is being evaluated or when doubt with constrictive pericarditis remains. In the restrictive phenotype, elevated filling pressures, possible equalization of end-diastolic pressures, a dip-and-plateau diastolic curve and increased pulmonary capillary wedge pressure are observed. However, some hemodynamic findings traditionally associated with constriction may overlap. Simultaneous respiratory assessment of ventricular pressures is therefore more useful than the simple finding of elevated pressures: marked respiratory systolic discordance between the right and left ventricles favors constriction, whereas in myocardial restriction the pressures tend to vary more concordantly.
Endomyocardial biopsy must be considered a precision test, not a routine procedure for all patients. It is appropriate when the diagnosis remains uncertain despite advanced imaging, when amyloidosis, sarcoidosis, storage diseases, iron overload, myocarditis, specific toxicities or endomyocardial diseases are suspected, or when the result may change therapeutic management. Histological examination may show non-specific interstitial fibrosis, disarray, infiltrates, amyloid deposits with dedicated stains, iron, granulomas, neoplastic infiltration, fibrotic endocardium or myocellular abnormalities. A non-diagnostic biopsy does not always exclude disease, because sampling may miss focal lesions; for this reason, the procedure must be integrated with imaging and selection of the most informative site.
The differential diagnosis must remain broad until the end. Hypertensive heart disease with diastolic dysfunction produces dilated atria and elevated pressures, but usually has a history of hypertension, consistent hypertrophy and less severe pure restriction. Advanced hypertrophic cardiomyopathy may develop restrictive physiology, but retains morphological, genetic or familial clues. End-stage dilated cardiomyopathy may show restrictive filling, but the ventricles are dilated or hypokinetic. Mitral and tricuspid valve diseases must be excluded because they can dilate the atria and generate congestion. Ischemic heart disease may produce diastolic dysfunction, but the clinical context, coronary angiography or coronary computed tomography clarifies the coronary contribution. The true diagnosis of idiopathy arises only after this progressive subtraction.
Idiopathic restrictive cardiomyopathy does not have a single universally adopted classification as some oncological or valvular diseases do. The most useful classification in practice is phenotypic and etiological: first, restrictive physiology is recognized, then it is established whether the form is primary or secondary, genetic or non-genetic, isolated or syndromic, pure or overlapping with other cardiomyopathic phenotypes. This approach prevents the error of considering restriction as a final diagnosis when it is, in reality, a way in which the heart expresses different diseases.
The pure idiopathic form describes the patient with persistent restrictive physiology, non-dilated ventricles, dilated atria and no recognized cause. This group includes sporadic cases without family history, without extracardiac signs and without identified pathogenic or likely pathogenic genetic variants. However, it is a group destined to shrink as diagnostics advance. Whenever a cause is demonstrated, the diagnosis must be updated: a form with a sarcomeric variant is no longer simply idiopathic, a form with amyloid deposition is not idiopathic, a form with Anderson-Fabry disease or iron overload is not idiopathic.
The apparently idiopathic primary genetic form includes patients in whom the initial presentation does not suggest a systemic disease, but genetic testing identifies a plausibly causal variant. Sarcomeric variants may produce pure restrictive pictures, pictures overlapping with hypertrophic cardiomyopathy or familial phenotypes in which different members express hypertrophic, dilated or restrictive cardiomyopathy, or sudden death. This phenomenon of variable expressivity is particularly important in family counseling: the same molecular alteration may not produce the same clinical picture in all carriers.
A second distinction concerns age at presentation. Pediatric forms are often more aggressive, may rapidly lead to pulmonary hypertension and transplantation, and require particular attention to the timing of referral to expert centers. Adult forms may be slower, but should not be underestimated because onset with atrial fibrillation, pulmonary hypertension or right-sided congestion may indicate already advanced disease. In older adults, the main problem is preventing wild-type transthyretin cardiac amyloidosis, meaning non-hereditary transthyretin amyloidosis, from being erroneously labeled as idiopathic.
Classification by hemodynamic severity is useful for prognosis and treatment. An initial form may have exertional symptoms, filling pressures elevated only during exercise and preserved systolic function. An intermediate form presents with congestion at rest, marked atrial dilatation, atrial fibrillation or stable increase in natriuretic peptides. An advanced form combines low output, significant pulmonary hypertension, right ventricular dysfunction, functional tricuspid regurgitation, renal deterioration, cardiac cachexia or repeated hospitalizations. This stratification does not replace diagnosis, but guides follow-up frequency and possible transplant evaluation.
An additional level concerns the electrical phenotype. Some patients have predominantly mechanical disease, with sinus rhythm maintained for years; others develop early atrial fibrillation, atrial flutter, atrial tachycardias, atrioventricular blocks or ventricular arrhythmias. The electrical phenotype is not only a complication: it may be an etiological clue. Conduction blocks and ventricular arrhythmias should prompt investigation for laminopathies, desminopathies, filaminopathies, sarcoidosis or neuromuscular diseases; early atrial fibrillation with markedly dilated atria often reflects the severity of filling pressures and increases embolic risk.
Finally, classification must remain dynamic. A patient may be diagnosed as idiopathic today and reclassified after the appearance of extracardiac signs, a new family history, improvement of genetic panels, reassessment of a variant, targeted biopsy or new evidence of systemic disease. For this reason, follow-up must include periodic reassessment of etiology, not only symptom monitoring. In rare cardiomyopathies, an apparently definitive diagnosis may become incomplete if it is not updated in light of new clinical and scientific data.
The treatment of idiopathic restrictive cardiomyopathy is complex because there is no validated etiological therapy capable of correcting primary myocardial stiffness. Management is based on three objectives: relieving congestion without excessively reducing ventricular filling, preventing and treating arrhythmias and thromboembolism, and identifying early those patients who should be evaluated for heart transplantation. Every treatment must respect the physiology of the disease: the ventricle is stiff, stroke volume is relatively fixed and output depends on a delicate balance between heart rate, rhythm, preload and vascular resistance.
Loop diuretics are often necessary to control edema, ascites, hepatic congestion, effusions and dyspnea due to increased filling pressures. However, they must be titrated carefully. Excessive preload reduction may abruptly decrease stroke volume and worsen hypotension, syncope, renal failure and low output. In congested patients, moderate sodium restriction, weight monitoring, monitoring of renal function and electrolytes, dose adjustment according to symptoms and careful evaluation of hyponatremia, hypokalemia or hypotension may be useful. Diuretic therapy is therefore symptomatic, not disease-modifying.
Medications used in heart failure with reduced ejection fraction do not have the same evidence base in idiopathic restrictive cardiomyopathy with preserved ejection fraction. Renin-angiotensin-aldosterone system inhibitors, beta-blockers, mineralocorticoid receptor antagonists and sodium-glucose cotransporter type 2 inhibitors may be indicated for comorbidities or for specific heart failure phenotypes, but they must not be applied automatically as if the condition were dilated cardiomyopathy. Beta-blockers and negative chronotropic medications may worsen exercise tolerance or output if they induce bradycardia in a patient with fixed stroke volume; excessive vasodilators may be poorly tolerated if they cause hypotension.
Sinus rhythm should be preserved whenever possible. Atrial fibrillation is often poorly tolerated and may cause rapid worsening of congestion; for this reason, when the clinical context allows, a rhythm-control strategy may be preferable to simple rate control. Electrical cardioversion, antiarrhythmic medications, transcatheter ablation or hybrid management should be evaluated in expert centers, considering atrial size, arrhythmia duration, proarrhythmic risk and ventricular function. Anticoagulation is indicated in the presence of atrial fibrillation according to general recommendations, but in clinical practice thromboembolic risk may be high also because of enormously dilated atria, slow flow, atrial thrombi or embolic history; the decision must be individualized.
Bradyarrhythmias and atrioventricular blocks require particular attention. In some patients, pacemaker implantation may be necessary to maintain an adequate heart rate and prevent syncope or low output. When chronic right ventricular pacing risks worsening ventricular synchrony, the choice of pacing mode must be carefully considered. The indication for an implantable defibrillator is not automatic on the basis of idiopathic restrictive cardiomyopathy alone; it must consider documented ventricular arrhythmias, suspected arrhythmic syncope, systolic function, fibrosis, family history of sudden death, genotype and general recommendations for inherited cardiomyopathies.
Treatment of the cause remains central whenever a cause is identified. If light-chain amyloidosis, transthyretin amyloidosis, hemochromatosis, sarcoidosis, Anderson-Fabry disease, hypereosinophilia, autoimmune disease or storage disease emerges during the diagnostic pathway, treatment must be redirected toward the specific disorder. This point is essential because idiopathy must not become a label that blocks the search for disease-modifying therapies. An alternative diagnosis may open the way to iron chelation, enzyme replacement or chaperone therapy, selected immunosuppression, anti-plasma cell therapies, transthyretin stabilizers or targeted treatments according to the disease.
Heart transplantation is the only option capable of radically modifying prognosis in patients with advanced uncontrolled disease. It should be considered early in subjects with severe symptoms, repeated hospitalizations, low output, progressive pulmonary hypertension, right ventricular dysfunction, syncope, relevant arrhythmias or inability to control congestion without compromising kidney function and arterial pressure. In children and young adults, transplant evaluation must be timely, because pulmonary hypertension may become a limitation to transplantation if pulmonary vascular remodeling becomes fixed. Ventricular assist devices are often more difficult to use than in dilated cardiomyopathies, because the small and stiff ventricular cavity may make drainage from the left ventricle problematic.
Prognosis is variable but overall serious. Unfavorable factors include pediatric age with symptoms, heart failure at diagnosis, pulmonary hypertension, right ventricular dysfunction, reduced fractional shortening or systolic function, persistent atrial arrhythmias, syncope, ventricular arrhythmias, elevated natriuretic peptides, need for high-dose diuretics, renal failure, cachexia and genotypes associated with an aggressive course. Transplant-free survival in historical pediatric series is low compared with other cardiomyopathies, whereas in adults it depends greatly on timeliness of diagnosis, the possibility of excluding and treating specific causes and management in centers experienced in rare cardiomyopathies.
Follow-up must be close and multidisciplinary. Symptoms, functional class, weight, arterial pressure, rhythm, renal function, electrolytes, B-type natriuretic peptide or the N-terminal fragment of pro-B-type natriuretic peptide, echocardiography, right ventricular function, estimated pulmonary pressure and arrhythmic burden by Holter or prolonged monitoring when indicated must be monitored. In genetic cases or suspected genetic cases, a cardiologist experienced in cardiomyopathies, a geneticist, a pediatric cardiologist if the patient is young, a family counselor and, in advanced cases, a transplant center must be involved. Episodic management limited to edema therapy is not sufficient for a disease with a risk of sudden deterioration.
Complications derive directly from ventricular stiffness, chronic atrial pressure, atrial dilatation, venous congestion and the electrical vulnerability of the myocardium. The most frequent is congestive heart failure, which may be predominantly left-sided, right-sided or biventricular. Increased left-sided filling pressures cause dyspnea, orthopnea, pulmonary interstitial edema and reduced exercise capacity; increased right-sided pressures produce jugular venous distension, hepatomegaly, ascites, peripheral edema, pleural effusions and renal congestion. Chronic congestion is not only a symptom: it alters renal function, hepatic function, muscle metabolism and quality of life.
Atrial fibrillation and atrial flutter are central complications. Dilated atria become an anatomical and electrical substrate favorable to arrhythmic circuits; when the arrhythmia develops, the stiff ventricle loses the contribution of atrial contraction and filling worsens. This loss may transform a stable condition into acute heart failure. A rapid ventricular rate further reduces diastole, whereas a rate that is too slow reduces output in a system that cannot adequately increase stroke volume. Rhythm management, therefore, is not only control of palpitations but hemodynamic protection.
Thromboembolic events are favored by atrial dilatation, atrial fibrillation, slow atrial flow, mechanical dysfunction of the appendage and systemic congestion. They may manifest as ischemic stroke, peripheral systemic embolism, renal embolism, mesenteric ischemia or pulmonary embolism if venous thrombosis and stasis coexist. In children and young adults, embolic risk may be particularly relevant because the disease may produce very large atria even in the absence of many traditional risk factors. Prevention requires early recognition of arrhythmias, accurate echocardiography and individualized evaluation of anticoagulation.
Pulmonary hypertension is a progressive pathophysiological complication. Initially it is post-capillary, due to retrograde transmission of elevated pressures from the left atrium to the pulmonary veins and capillaries. If exposure persists, the pulmonary circulation may develop vasoconstriction and arterial remodeling, with increased pulmonary vascular resistance. This transition is prognostically important because it increases right ventricular load, favors functional tricuspid regurgitation, reduces output and may complicate eligibility for heart transplantation. Invasive measurement becomes essential when distinguishing a reversible component from a fixed component is necessary.
Right ventricular dysfunction may occur for several reasons: chronic increase in pulmonary pressure, ventricular interdependence, restrictive involvement of the right ventricle, tricuspid regurgitation and reduced right coronary perfusion in conditions of high end-diastolic pressure. When the right ventricle fails, the clinical picture shifts toward systemic congestion, ascites, congestive hepatopathy, malabsorption, reduced renal perfusion and hypotension. Right-sided dysfunction is also an indicator of advanced disease and reduces the safety margin of diuretic therapy.
Hepatic and renal complications are frequent in advanced stages. Chronic hepatic congestion may cause increased transaminases, cholestasis, hyperbilirubinemia, hepatomegaly, right upper quadrant pain, ascites and, in prolonged pictures, congestive fibrosis. The kidney suffers from reduced output, increased renal venous pressure, diuretic use, neurohormonal activation and hypotension. This results in cardiorenal syndrome, with worsening renal function precisely when intensification of decongestion would be needed. This vicious circle is one of the reasons why patients should be referred early to expert centers.
Ventricular arrhythmias and sudden death are less predictable than in other cardiomyopathies, but they represent a possible complication, especially in the presence of fibrosis, high-risk genotypes, syncope, systolic dysfunction, family history or phenotypes with conduction disturbances. Sudden death may also depend on severe bradyarrhythmias, advanced atrioventricular block or electromechanical dissociation in the terminal phase. Risk stratification cannot be based on a single parameter; it must integrate electrocardiogram, Holter monitoring, imaging, family history, genetics, syncope and clinical course.
In pediatric forms, complications related to growth and development are added. Reduced cardiac output may limit physical activity, growth, nutrition, school attendance and psychosocial development; the need for anticoagulation, antiarrhythmics, hospitalizations and transplant evaluation profoundly changes the life of the child and family. The transition from pediatric to adult care also requires planning, because inherited or apparently idiopathic cardiomyopathies do not end with pediatric age and may involve other family members over time.
Finally, iatrogenic and management-related complications exist. Excessive volume depletion may cause syncope, renal failure and low output; overly aggressive rate control may worsen hemodynamics; underestimation of atrial fibrillation may precipitate heart failure and embolism; incomplete diagnosis may delay specific therapies for amyloidosis, iron overload, sarcoidosis or storage diseases. The most serious complication from a diagnostic point of view is therefore misclassification: calling a form idiopathic when it is not may deprive the patient of treatment, family screening and correct prognosis.